Does vitamin E bound on dialysis membrane improve the LDL susceptibility to oxidation? Lessons from an in vitro model

Contributions to Nephrology

Volumn 127, Issue , 1999, Pages 128-138

  Morena, M ^a   Cristol, J P ^a   Descomps, B ^a   Canaud, B ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; ARTIFICIAL MEMBRANE; BLOOD; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; RENAL REPLACEMENT THERAPY;

ANTIOXIDANTS; HUMANS; LIPOPROTEINS, LDL; MEMBRANES, ARTIFICIAL; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; RENAL DIALYSIS; VITAMIN E;

EID: 0033251184     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (36)

1. Lindner A, Charra B, Sherrard D, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
2. Loughrey CM, Yung IS, Lightbody JH, McMaster D, McNamee PT, Trimble ER: Oxidative stress in haemodialysis. Q J Med 1994;87:679-683.
3. Paul JL, Sall ND, Soni T, Poignet JL, Lindenbaum A, Man NK, Moatti N, Raichvarg D: Lipid peroxidation abnormalities in hemodialyzed patients. Nephron 1993; 64:106-109.
4. Kuroda M, Asaka S, Tofuku Y, Takeda R: Serum antioxidant activity in uremic patients. Nephron 1985;41:293-298.
5. Vlassara H: Serum advanced glycosylation end products: A new class of uremic toxins? Blood Purif 1994;12:54-59.
6. Makita Z: Toxicity of glucose: Is AGE the answer? Nephrol Dial Transplant 1995;10(suppl 7): 33-37.
7. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Zingraff J, Jungers P, Descamps-Latscha B: Advanced glycosylation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304-1313.
8. Maggi E, Bellazzi R, Falaschi F, Frattoni A, Perani G, Finardi G, Gazo A, Nai M, Romanini D, Bellomo G: Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis? Kidney Int 1994;45:876-883.
9. Himmelfard J, Lazarus M, Hakim R: Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 1991;17:271-276.
10. Cristol JP, Canaud B, Rabesandratana H, Gaillard I, Serre A, Mion C: Enhancement of reactive oxygen species production and cell surface markers expression during hemodialysis. Nephrol Dial Transplant 1994;9:389-394.
11. Saint-Georges MD, Bonnefont DJ, Bourely BA, Jaudon MCT, Cereze P, Chaumeil P, Gard C, D'auzq CL: Selenium deficiency correction in haemodialyzed patients. Kidney Int 1989;27:S274-S277.
12. Takahashi K, Newburger PE, Cohen HJ: Glutathione peroxidase protein: Absence in selenium deficiency and correlation with enzymatic activity. J Clin Invest 1986;77:1402-1404.
13. Richard MJ, Arnaud J, Jurkovitz C, Hachache T, Meftahi H, Laporte F, Foret M, Favier A, Cordonnier D: Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 1991;57:10-15.
14. Giardini O, Taccone-Gallucci M, Lubrano R, Ricciardi-Tenore G, Bandino D, Silvi I, Paradisi C, Mannarino O, Citti G, Elli M, Casciani CU: Effects of alpha-tocopherol administration on red blood cell membrane lipid peroxidation in hemodialysis patients. Clin Nephrol 1984;21:174-177.
15. Taccone-Gallucci M, Giardini O, Ausiello C, Piazza A, Spagnoli GC, Bandino D Lubrano R, Taggi F, Evangelista B, Monaco P, Tabilio MR, Valeri M, Citti G, Casciani CU: Vitamine E supplementation in hemodialysis patients: Effects on peripheral blood mononuclear cells lipid peroxidation and immune response. Clin Nephrol 1986;25:81-86.
16. Pastor MC, Sierra C, Bonal J, Teixido J: Serum and erythrocyte tocopherol in uremic patients: Effect of hemodialysis versus peritoneal dialysis. Am J Nephrol 1993;13:238-243.
17. Sullivan JF, Eisenstein AB: Ascorbic acid depletion in patients undergoing haemodialysis. Am J Clin Nutr 1970;23:1339-1346.
18. Descombes E, Hanck AB, Fellay G: Water-soluble vitamins in chronic hemodialysis patients and need for supplementation. Kidney Int 1993;43:19-28.
19. Cristol JP, Bosc JY, Badiou S, Leblanc M, Lorho R, Descomps B, Canaud B: Erythropoietin and oxidative stress in haemodialysis: Beneficial effects of vitamin E supplementation. Nephrol Dial Transplant 1997;12:2312-2317.
20. Steiner M: Vitamin E: More than an antioxidant. Clin Cardiol 1993;16:116-118.
21. Faruqi R, De La Motte C, Di Corteto PE: Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest 1994;94:592-600.
22. Chatelain E, Boscoboinik DO, Bartoli GM, Kagan VE, Gey FK, Packer L, Azzi A: Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim Biophys Acta 1990;1176:83-89.
23. Tran K, Chan AC: RRR alpha-tocopherol potentiates prostacyclin release in human endothelial cells. Evidence for the structural specificity of the tocopherol molecule. Biochim Biophys Acta 1990;1043:189-197.
24. Sakamoto W, Fujie K, Nishihira J, Handa H: Effect of vitamin E on arachidonic acid release in rat peritoneal macrophages. Biochim Biophys Acta 1993;1170:296-300.
25. Kanno T, Utsumi T, Kobuchi H, Takehara Y, Akiyama J, Yoshioka T, Horton AA, Utsumi K: Inhibition of stimulus-specific neutrophil superoxide generation by alpha-tocopherol. Free Radic Res 1995;22:431-440.
26. Sakamoto W, Fujie K, Handa H, Ogihara T, Mino M: In vivo inhibition of superoxide production and protein kinase C activity in macrophages from vitamin E-treated rats. Int J Vitam Nutr Res 1990;60:338-342.
27. Cachia O, Leger CL, Descomps B: Monocyte superoxide production is highly sensitive and inversely related to normal charges of low density lipoprotein in ·-tocopherol. Atherosclerosis 1998;138: 263-269.
28. Galli F, Rovidati S, Chiarantini L, Campus G, Canestrari F, Buoncristiani U: Bioreactivity and biocompatibility of a vitamin E-modified multilayer hemodialysis filter. Kidney Int 1998;54:580-589.
29. Vachier I, Chanez P, Le Doucen C, Damon M, Descomps B, Godard P: Enhancement of reactive oxygen species formation in stable and unstable asthmatic patients. Eur Respir J 1994;7:1585-1592.
30. Verne N, Schumaker D, Puppione L: Sequential flotation ultracentrifugation. Methods Enzymol 1986;128:155-170.
31. Esterbauer H, Striegl G, Pulh H, Rothender M: Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67-75.
32. Morena M, Vaussenat F, Maggi MF, Canaud B, Cristol JP, Descomps B: Modèlisation de la cinètique d'oxydation des LDL par un logiciel (logiciel NELOP) et validation dans une population à risques vasculaires. Soc Fr Rech Radic Libres CR Soc Biol (Paris) 1999; in press.
33. Esterbauer H, Gebicki J, Puhl H, Jürgens G: The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992;13:341-390.
34. Morena M, Cristol JP, Dantoine T, Carbonneau MA, Descomps B, Canaud B: Protective effects of HDL against oxidative stress are impaired in hemodialysis patients. Nephrol Dial Transplant 1999; submitted.
35. Rajman I, Harper L, McPake D, Kendall M, Wheeler D: Low-density lipoprotein subfraction profiles in chronic renal failure. Nephrol Dial Transplant 1998;13:2281-2287.
36. O'Neal D, Lee P, Murphy B, Best J: Low density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis. Am J Kidney Dis 1996;49:488-493.